Lung Cancer Metastasis-induced Distal Esophageal Segmental Spasm Confirmed by Individualized Peroral Endoscopic Myotomy: A Case Report

Overview

Journal World J Gastrointest Surg

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2024 Nov 22

PMID 39575281

Authors

Hong Shi

Su-Yu Chen

Zhao-Fei Xie

Li-Lin Lin

Yan Jiang

Affiliations

Soon will be listed here.

Abstract

Background: Peroral endoscopic myotomy (POEM) has been widely performed as a standard treatment for achalasia; however, its efficacy and safety for treating distal esophageal segmental spasms induced by cancer metastasis remain unknown.

Case Summary: A 72-year-old male was referred to our hospital and complained of progressive dysphagia for two years. Endoscopy revealed a 2 cm long segment esophageal stenosis with intact mucosa and normal cardia. Computed tomography showed a right upper lung mass, and pathology of the right pleural effusion confirmed the diagnosis of right upper lung adenocarcinoma with multiple rib and mediastinal lymph node metastases and right malignant pleural effusion. Individualized POEM was performed first to alleviate dysphagia, and the final diagnosis was changed to esophageal muscle metastasis arising from lung adenocarcinoma. After treatment, the patient could eat soft solid food and received multiple rounds of pembrolizumab-combination chemotherapy. The patient's progression-free survival was approximately 16 months. Long stable disease was obtained during the 24-month follow-up.

Conclusion: The incidence of distal esophageal segmental spasms induced by muscular metastasis arising from lung adenocarcinoma is extremely low. Individualized POEM can effectively improve a patient's nutritional status before subsequent chemotherapy can be combined with immune checkpoint inhibitors.

References

Rossi D . Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience. Lung Cancer. 2020; 145:83-84. PMC: 7201225. DOI: 10.1016/j.lungcan.2020.05.001. View

Arrieta O, Barron F, Ramirez-Tirado L, Zatarain-Barron Z, Cardona A, Diaz-Garcia D . Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial. JAMA Oncol. 2020; 6(6):856-864. PMC: 7290397. DOI: 10.1001/jamaoncol.2020.0409. View

Ramirez-Ferrer E, Aguilera-Pena M, Duffau H . Functional and oncological outcomes after right hemisphere glioma resection in awake versus asleep patients: a systematic review and meta-analysis. Neurosurg Rev. 2024; 47(1):160. DOI: 10.1007/s10143-024-02370-8. View

Garassino M, Gadgeel S, Speranza G, Felip E, Esteban E, Domine M . Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study. J Clin Oncol. 2023; 41(11):1992-1998. PMC: 10082311. DOI: 10.1200/JCO.22.01989. View

Rao S, Min L, Zhao J, Su J, Ye L . Efficacy of consolidation of immune checkpoint inhibitor after chemoradiation for unresectable, locally advanced PD‑L1 negative non‑small cell lung cancer: A systematic review and meta‑analysis. Oncol Lett. 2024; 27(6):242. PMC: 11008101. DOI: 10.3892/ol.2024.14375. View

Borghaei H, Gettinger S, Vokes E, Chow L, Burgio M, de Castro Carpeno J . Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer. J Clin Oncol. 2021; 39(7):723-733. PMC: 8078445. DOI: 10.1200/JCO.20.01605. View

Horinouchi H, Nogami N, Saka H, Nishio M, Tokito T, Takahashi T . Pembrolizumab plus pemetrexed-platinum for metastatic nonsquamous non-small-cell lung cancer: KEYNOTE-189 Japan Study. Cancer Sci. 2021; 112(8):3255-3265. PMC: 8353942. DOI: 10.1111/cas.14980. View

Ren Y, Tang X, Chen Y, Chen F, Zou Y, Deng Z . Pre-treatment Eckardt score is a simple factor for predicting one-year peroral endoscopic myotomy failure in patients with achalasia. Surg Endosc. 2016; 31(8):3234-3241. DOI: 10.1007/s00464-016-5352-5. View

Gandhi L, Rodriguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F . Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. N Engl J Med. 2018; 378(22):2078-2092. DOI: 10.1056/NEJMoa1801005. View

10.

Minaga K, Takenaka M, Katanuma A, Kitano M, Yamashita Y, Kamata K . Needle Tract Seeding: An Overlooked Rare Complication of Endoscopic Ultrasound-Guided Fine-Needle Aspiration. Oncology. 2017; 93 Suppl 1:107-112. DOI: 10.1159/000481235. View

11.

Mu D, Li Y, Zhang M, Zhang Y, Li Z, Li Y . POEM for special patient cohorts: A review. J Dig Dis. 2017; 18(5):265-272. DOI: 10.1111/1751-2980.12473. View

12.

Saez de la Fuente I, Chacon Alves S, Molina Collado Z . Pleural migration of esophageal stent. Med Intensiva (Engl Ed). 2023; 48(1):64-65. DOI: 10.1016/j.medine.2023.10.002. View

13.

Maselli R, Spadaccini M, Pellegatta G, Repici A . Peroral Endoscopic Myotomy Technique, from Mouth to Anus. Gastrointest Endosc Clin N Am. 2022; 33(1):127-142. DOI: 10.1016/j.giec.2022.09.008. View

14.

Vergnenegre A, Monnet I, Ricordel C, Bizieux A, Curcio H, Bernardi M . Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo). Lung Cancer. 2023; 178:191-197. DOI: 10.1016/j.lungcan.2023.02.020. View

15.

Yamamoto M, Nishida T, Uema R, Kanesaka T, Ogawa H, Kitamura S . Utility and advantage of the unroofing technique for gastrointestinal subepithelial tumors: A multicenter retrospective cohort study. DEN Open. 2024; 4(1):e332. PMC: 10797821. DOI: 10.1002/deo2.332. View

16.

Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M . Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010; 42(4):265-71. DOI: 10.1055/s-0029-1244080. View

17.

Shimamura Y, Fujiyoshi Y, Fujiyoshi M, Inoue H . Evolving field of third-space endoscopy: Derivatives of peroral endoscopic myotomy. Dig Endosc. 2022; 35(2):162-172. DOI: 10.1111/den.14400. View

18.

Hirdes M, Vleggaar F, Siersema P . Stent placement for esophageal strictures: an update. Expert Rev Med Devices. 2011; 8(6):733-55. DOI: 10.1586/erd.11.44. View

19.

Chen S, Xie Z, Jiang Y, Lin J, Shi H . Modified endoscopic submucosal tunnel dissection for large esophageal submucosal gland duct adenoma: A case report. World J Gastrointest Surg. 2023; 15(5):1000-1006. PMC: 10277952. DOI: 10.4240/wjgs.v15.i5.1000. View

20.

Feng J, Ali R, Hao J, Kong G, Yang L, Huang X . Peroral endoscopic myotomy for esophageal motility disorders. Esophagus. 2019; 17(1):11-18. PMC: 6976553. DOI: 10.1007/s10388-019-00693-w. View